**Core Concept**
The patient has multiple clotting factor deficiency, which indicates a coagulopathy. In such cases, the primary goal is to replace the deficient clotting factors to achieve hemostasis. The ideal blood product should contain all the necessary clotting factors to prevent further bleeding.

**Why the Correct Answer is Right**
Fresh Frozen Plasma (FFP) is the best choice in this scenario. FFP contains all the clotting factors, including vitamin K-dependent factors (II, VII, IX, X), as well as fibrinogen. When thawed, FFP provides a broad range of clotting factors, which can help to correct the coagulopathy and control bleeding. FFP is particularly useful in patients with multiple clotting factor deficiencies, as it can provide a rapid and effective way to restore coagulation.

**Why Each Wrong Option is Incorrect**
**Option A:** Cryoprecipitate is a concentrated source of fibrinogen and factors VIII and XIII, but it lacks the majority of the other clotting factors. Therefore, it is not the best choice for a patient with multiple clotting factor deficiencies.
**Option B:** Platelets are essential for platelet plug formation, but they do not contain clotting factors. In a patient with multiple clotting factor deficiencies, platelets alone may not be sufficient to control bleeding.
**Option C:** Whole Blood is a mixture of red blood cells, platelets, and plasma. While it may contain some clotting factors, it is not a concentrated source and may not provide adequate factor replacement for a patient with multiple clotting factor deficiencies.

**Clinical Pearl / High-Yield Fact**
Cryoprecipitate is often used in patients with significant fibrinogen deficiency, such as those with severe trauma or postpartum hemorrhage. However, it should not be used as a substitute for FFP in patients with multiple clotting factor deficiencies.

**Correct Answer:** C. Fresh Frozen Plasma (FFP)